Clinical Trial Update: Herombopag + rhTPO in Severe Immune Thrombocytopenia [Phase 3]

View source ↗

Summary

Phase 3 trial update for Herombopag plus rhTPO in severe immune thrombocytopenia is reported with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Herombopag (herombopag)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Yin Jie | Conditions: Immune Thrombocytopenia | Phase 3 | Status: UNKNOWN